Signature talk · 01
Decentralized Clinical Trials — Beyond the Hype
Twelve years building the platforms behind DCTs — what's worked, what didn't, and what the next chapter actually looks like for sponsors.
Digital Clinical Development · Life Sciences
Inside the digital transformation of clinical development.
Joe Dustin has spent 20+ years across pharma, eClinical technology, and industry organizations setting the strategic direction for clinical development.
Digital Clinical Development · Life Sciences
Inside the digital transformation of clinical development.
Joe Dustin has spent 20+ years across pharma, eClinical technology, and industry organizations setting the strategic direction for clinical development.
Career across
- Medidata
- Bristol Myers Squibb
- Medable
- Biofourmis
- TransCelerate
- DIA
What I do
A career at the intersection of clinical science, technology, and the people we serve.
I have never built or managed a clinical trial on paper. I am a digital native and I’ve spent most of my career inside the digital transformation of clinical development - from 12 years in the commercial and product teams at Medidata, to leading clinical innovation at Bristol Myers Squibb, to running product strategy at Medable and Biofourmis.
The real work isn’t about smarter systems. It’s about building trust, leading with intention, and creating change that respects both the science and the people it serves.
Focus areas
Where my work lives.
01
Digital & Decentralized Trials
Twelve years building the Patient Cloud and DCT platform at Medidata; product strategy for DCT and eCOA at Medable and Biofourmis. The operational reality behind the marketing.
02
eCOA, eSource & the Clinical Data Stack
Former VP & GM of eCOA at Medable. Co-Lead of TransCelerate's eSource DDF Initiative. The technology, the workflow, and the regulatory expectations that hold it together.
03
Clinical Innovation & Change Management
Headed Clinical Innovation and Change Management at Bristol Myers Squibb — taking ideas from pilot through enterprise-scale adoption inside Global Development Operations.
04
AI in Drug Development
Translating AI capability into operational reality for sponsors, eClinical platforms, and the investors funding the next wave of pharmatech.
A note on availability
“I work full-time in life sciences. The conversations I welcome here are the ones where my perspective on digital clinical development can contribute meaningfully as a director, advisor, or speaker to mission-aligned organizations.”
All board, advisory, and speaking inquiries are reviewed personally and evaluated for alignment, fit, and any conflict considerations with my current professional commitments.
In the news
On the stage and in the conversation.
Signature talk · 02
Building the Modern eClinical Stack
How sponsors connect EDC, eCOA, eSource, ePRO, sensors, and RWD into something operationally real — and regulator-defensible.
Signature talk · 03
AI in Clinical Development
Where AI is genuinely changing trial operations — and where it's still a slide deck looking for a clinical workflow.
Recent venues & formats
Board & advisory
Operator depth in the boardroom.
I currently chair DIA’s Regional Advisory Board for the Americas - a cross-industry council that advises DIA executive leadership and the Board of Directors on the trends and national issues shaping life sciences. I am also on several advisory boards within the industry.
I selectively join additional boards and advisory committees where subject matter expertise in Clinical Trials, Clinical Operations and Digital Transformation is core to the mission.
- Clinical technology and pharmatech company boards
- Scientific & strategic advisory boards
- Investor diligence and portfolio advisory
- Industry-association boards and councils
Writing
Selected work, and what’s next.
Bylines in Forbes, Applied Clinical Trials, Outsourcing-Pharma, and Med-Tech News. Follow on Substack for new notes, blogs, and essays on the eClinical stack, DCTs, and AI in clinical development.
Applied Clinical Trials · 2023
Clinical Trial Optionality: Its Reality Is Within Reach
Why ‘optionality’ — not standardization — is the operating model sponsors actually need to build the next generation of trials.
Read at Applied Clinical Trials →Forbes · 2016
Pharma Is Long Due for a Disruption
On why drug development’s pace and economics can’t outrun the cost of the status quo — and what a real disruption looks like from inside.
Read at Forbes →Outsourcing-Pharma · 2018
What Apple's Health Records Update Means for the Clinical Trials Industry
An early read on consumer health-data interoperability and what it would (and wouldn’t) actually change for clinical research.
Read at Outsourcing-Pharma →Get in touch
For board, advisory, speaking, and media inquiries.
I review every inquiry personally. Not available for consulting engagements.